Atea Pharmaceuticals, Inc.
AVIR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$168,385 | -$135,956 | -$115,909 | $121,190 |
| Dep. & Amort. | $416 | $416 | $260 | $29 |
| Deferred Tax | $0 | -$48,559 | $0 | -$29,390 |
| Stock-Based Comp. | $51,767 | $49,428 | $46,718 | $39,621 |
| Change in WC | -$7,476 | $16,163 | -$46,586 | -$247,845 |
| Other Non-Cash | -$11,821 | $33,113 | -$5,465 | $29,390 |
| Operating Cash Flow | -$135,499 | -$85,395 | -$120,982 | -$87,005 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$1,943 | -$4 |
| Net Acquisitions | $0 | $0 | $453 | $0 |
| Inv. Purchases | -$461,177 | -$562,362 | -$545,352 | $0 |
| Inv. Sales/Matur. | $517,282 | $602,665 | $91,885 | $0 |
| Other Inv. Act. | $0 | $0 | -$453 | $0 |
| Investing Cash Flow | $56,105 | $40,303 | -$455,410 | -$4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $267 | $257 | $230 | $1,465 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $140 | $0 |
| Financing Cash Flow | $267 | $257 | $370 | $1,465 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$79,127 | -$44,835 | -$576,022 | -$85,544 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $143,823 | $188,658 | $764,680 | $850,224 |
| End Cash | $64,696 | $143,823 | $188,658 | $764,680 |
| Free Cash Flow | -$135,499 | -$85,395 | -$122,925 | -$87,009 |